ESID Grand Round 7: HSCT for adults with IEI

In this ESID Grand Rounds webinar, two distinguished physicians will carry out an discussion about HSCT for adults with IEI. Dr. Jennifer A. Kanakry will present novel, reduced-intensity and reduced-toxicity approaches to allogeneic hematopoietic cell transplantation for patients with primary immunodeficiency diseases and primary immune regulatory disorders will be discussed, as well as barriers to success. The title of her talk is "Reduced myeloid toxicity with augmented host lymphodepletion and robust immune reconstitution – novel approaches to allogeneic hematopoietic cell transplantation for immunodeficiencies at the National Institutes of Health". Prof. Emma C. Morris will discuss the recent developments and international results in allogeneic HSCT for adult patients with PID. The title of her talk is "HSCT for adults with PID: Who? Why? When, and how?". After participating in this webinar, participants should be able to: . To learn about risk factors determining HSCT outcomes in adolescents and adults with IEI . To understand how to identify suitable candidates for HSCT . To learn about sensible donor choices and conditioning regimens for these patients